惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
V
Visual Studio Blog
IT之家
IT之家
博客园 - 聂微东
The Cloudflare Blog
月光博客
月光博客
阮一峰的网络日志
阮一峰的网络日志
S
SegmentFault 最新的问题
Apple Machine Learning Research
Apple Machine Learning Research
酷 壳 – CoolShell
酷 壳 – CoolShell
爱范儿
爱范儿
H
Help Net Security
博客园 - 叶小钗
V
V2EX
WordPress大学
WordPress大学
J
Java Code Geeks
Hugging Face - Blog
Hugging Face - Blog
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
博客园_首页
C
Check Point Blog
B
Blog
D
DataBreaches.Net
美团技术团队
罗磊的独立博客

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Zevra Therapeutics, Inc. (ZVRA) Q1 2026 Earnings Call Tra...
2026-05-07 · via All Articles on Seeking Alpha

Zevra Therapeutics, Inc. (ZVRA) Q1 2026 Earnings Call May 6, 2026 4:30 PM EDT

Company Participants

Nichol Ochsner - Vice President of Investor Relations & Corporate Communications
Neil McFarlane - President, CEO & Director
Joshua Schafer - Chief Commercial Officer
Justin Renz - CFO & Treasurer

Conference Call Participants

Kambiz Yazdi - BTIG, LLC, Research Division
Sumant Kulkarni - Canaccord Genuity Corp., Research Division
Eddie Hickman - Guggenheim Securities, LLC, Research Division
Jason Butler - Citizens JMP Securities, LLC, Research Division
Brandon Folkes - H.C. Wainwright & Co, LLC, Research Division

Presentation

Operator

Good afternoon, and thank you for joining Zevra's First Quarter 2026 Financial Results and Corporate Update Conference Call. Today's call is being recorded and will be available via the Investor Relations section of the company's website later today. The host for today's call is Nichol Ochsner, Zevra's Vice President of Investor Relations and Corporate Communications.

Nichol Ochsner
Vice President of Investor Relations & Corporate Communications

Thank you, and welcome to those who are joining us. Today, we will provide an overview of our recent accomplishments, followed by a review of our first quarter 2026 financial results. I encourage you to read our financial results news release, which was distributed this afternoon and is available in the Investors section of our website.

Before we begin the call, please note that certain information shared today will include forward-looking statements. Actual results may differ materially from those stated or implied in any forward-looking statements due to risks and uncertainties associated with Zevra's business. Forward-looking statements are not promises or guarantees and are inherently subject to risks, uncertainties and other important factors that may lead to actual results differing materially from projections made and should be evaluated together with the Risk Factors section in our most recent quarterly report on Form 10-Q, our annual report on Form 10-K and our filings